Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 590 entries
Sorted by: Best Match Show Resources per page
Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus.

ISRN gastroenterology

Mizoshita T, Tanida S, Tsukamoto H, Ozeki K, Katano T, Ebi M, Mori Y, Kataoka H, Kamiya T, Joh T.
PMID: 23691335
ISRN Gastroenterol. 2013 Apr 09;2013:304894. doi: 10.1155/2013/304894. Print 2013.

Background. Tacrolimus (FK506) is effective for patients with ulcerative colitis (UC). However, there are few reports on tacrolimus therapy (TT) with respect to the relationship with endoscopic and clinicopathologic findings. Methods. Thirty patients with moderate/severe active UC refractory to...

Cite
Mizoshita T, Tanida S, Tsukamoto H, et al. Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus. ISRN Gastroenterol. 2013;2013:304894doi: 10.1155/2013/304894.
Mizoshita, T., Tanida, S., Tsukamoto, H., Ozeki, K., Katano, T., Ebi, M., Mori, Y., Kataoka, H., Kamiya, T., & Joh, T. (2013). Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus. ISRN gastroenterology, 2013304894. https://doi.org/10.1155/2013/304894
Mizoshita, Tsutomu, et al. "Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus." ISRN gastroenterology vol. 2013 (2013): 304894. doi: https://doi.org/10.1155/2013/304894
Mizoshita T, Tanida S, Tsukamoto H, Ozeki K, Katano T, Ebi M, Mori Y, Kataoka H, Kamiya T, Joh T. Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus. ISRN Gastroenterol. 2013 Apr 09;2013:304894. doi: 10.1155/2013/304894. Print 2013. PMID: 23691335; PMCID: PMC3649514.
Copy Download .nbib Format: NLM
Development and characterization of 27 microsatellite markers for the mangrove fern, Acrostichum aureum (Pteridaceae).

Applications in plant sciences

Yamamoto T, Tsuda Y, Mori GM, Cruz MV, Shinmura Y, Wee AK, Takayama K, Asakawa T, Yamakawa T, Suleiman M, Núñez-Farfán J, Webb EL, Watano Y, Kajita T.
PMID: 27672519
Appl Plant Sci. 2016 Sep 19;4(9). doi: 10.3732/apps.1600042. eCollection 2016 Sep.

PREMISE OF THE STUDY: Twenty-seven nuclear microsatellite markers were developed for the mangrove fern, Acrostichum aureum (Pteridaceae), to investigate the genetic structure and demographic history of the only pantropical mangrove plant.METHODS AND RESULTS: Fifty-six A. aureum individuals from three...

Cite
Yamamoto T, Tsuda Y, Mori GM, et al. Development and characterization of 27 microsatellite markers for the mangrove fern, Acrostichum aureum (Pteridaceae). Appl Plant Sci. 2016;4(9)doi: 10.3732/apps.1600042.
Yamamoto, T., Tsuda, Y., Mori, G. M., Cruz, M. V., Shinmura, Y., Wee, A. K., Takayama, K., Asakawa, T., Yamakawa, T., Suleiman, M., Núñez-Farfán, J., Webb, E. L., Watano, Y., & Kajita, T. (2016). Development and characterization of 27 microsatellite markers for the mangrove fern, Acrostichum aureum (Pteridaceae). Applications in plant sciences, 4(9), . https://doi.org/10.3732/apps.1600042
Yamamoto, Takashi, et al. "Development and characterization of 27 microsatellite markers for the mangrove fern, Acrostichum aureum (Pteridaceae)." Applications in plant sciences vol. 4,9 (2016). doi: https://doi.org/10.3732/apps.1600042
Yamamoto T, Tsuda Y, Mori GM, Cruz MV, Shinmura Y, Wee AK, Takayama K, Asakawa T, Yamakawa T, Suleiman M, Núñez-Farfán J, Webb EL, Watano Y, Kajita T. Development and characterization of 27 microsatellite markers for the mangrove fern, Acrostichum aureum (Pteridaceae). Appl Plant Sci. 2016 Sep 19;4(9). doi: 10.3732/apps.1600042. eCollection 2016 Sep. PMID: 27672519; PMCID: PMC5033363.
Copy Download .nbib Format: NLM
MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation.

Journal of clinical medicine

Kagiya T.
PMID: 26343739
J Clin Med. 2015 Aug 28;4(9):1741-52. doi: 10.3390/jcm4091741.

Osteolytic bone metastasis frequently occurs in the later stages of breast, lung, and several other cancers. Osteoclasts, the only cells that resorb bone, are hijacked by tumor cells, which break down bone remodeling systems. As a result, osteolysis occurs...

Cite
Kagiya T. MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation. J Clin Med. 2015;4(9):1741-52doi: 10.3390/jcm4091741.
Kagiya, T. (2015). MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation. Journal of clinical medicine, 4(9), 1741-52. https://doi.org/10.3390/jcm4091741
Kagiya, Tadayoshi. "MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation." Journal of clinical medicine vol. 4,9 (2015): 1741-52. doi: https://doi.org/10.3390/jcm4091741
Kagiya T. MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation. J Clin Med. 2015 Aug 28;4(9):1741-52. doi: 10.3390/jcm4091741. PMID: 26343739; PMCID: PMC4600156.
Copy Download .nbib Format: NLM
Electric field-induced superconducting transition of insulating FeSe thin film at 35 K.

Proceedings of the National Academy of Sciences of the United States of America

Hanzawa K, Sato H, Hiramatsu H, Kamiya T, Hosono H.
PMID: 27035956
Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):3986-90. doi: 10.1073/pnas.1520810113. Epub 2016 Mar 28.

It is thought that strong electron correlation in an insulating parent phase would enhance a critical temperature (Tc) of superconductivity in a doped phase via enhancement of the binding energy of a Cooper pair as known in high-Tc cuprates....

Cite
Hanzawa K, Sato H, Hiramatsu H, et al. Electric field-induced superconducting transition of insulating FeSe thin film at 35 K. Proc Natl Acad Sci U S A. 2016;113(15):3986-90doi: 10.1073/pnas.1520810113.
Hanzawa, K., Sato, H., Hiramatsu, H., Kamiya, T., & Hosono, H. (2016). Electric field-induced superconducting transition of insulating FeSe thin film at 35 K. Proceedings of the National Academy of Sciences of the United States of America, 113(15), 3986-90. https://doi.org/10.1073/pnas.1520810113
Hanzawa, Kota, et al. "Electric field-induced superconducting transition of insulating FeSe thin film at 35 K." Proceedings of the National Academy of Sciences of the United States of America vol. 113,15 (2016): 3986-90. doi: https://doi.org/10.1073/pnas.1520810113
Hanzawa K, Sato H, Hiramatsu H, Kamiya T, Hosono H. Electric field-induced superconducting transition of insulating FeSe thin film at 35 K. Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):3986-90. doi: 10.1073/pnas.1520810113. Epub 2016 Mar 28. PMID: 27035956; PMCID: PMC4839426.
Copy Download .nbib Format: NLM
Effects of young barley leaf powder on gastrointestinal functions in rats and its efficacy-related physicochemical properties.

Evidence-based complementary and alternative medicine : eCAM

Ikeguchi M, Tsubata M, Takano A, Kamiya T, Takagaki K, Ito H, Sugawa-Katayama Y, Tsuji H.
PMID: 25114709
Evid Based Complement Alternat Med. 2014;2014:974840. doi: 10.1155/2014/974840. Epub 2014 Jul 08.

Young barley leaf is consumed as a popular green-colored drink, which is named "Aojiru" in Japan. In the present study, we examined effects of young barley leaf powder (BL) on gastrointestinal transit time (GTT) and fecal moisture and weight...

Cite
Ikeguchi M, Tsubata M, Takano A, et al. Effects of young barley leaf powder on gastrointestinal functions in rats and its efficacy-related physicochemical properties. Evid Based Complement Alternat Med. 2014;2014:974840doi: 10.1155/2014/974840.
Ikeguchi, M., Tsubata, M., Takano, A., Kamiya, T., Takagaki, K., Ito, H., Sugawa-Katayama, Y., & Tsuji, H. (2014). Effects of young barley leaf powder on gastrointestinal functions in rats and its efficacy-related physicochemical properties. Evidence-based complementary and alternative medicine : eCAM, 2014974840. https://doi.org/10.1155/2014/974840
Ikeguchi, Motoya, et al. "Effects of young barley leaf powder on gastrointestinal functions in rats and its efficacy-related physicochemical properties." Evidence-based complementary and alternative medicine : eCAM vol. 2014 (2014): 974840. doi: https://doi.org/10.1155/2014/974840
Ikeguchi M, Tsubata M, Takano A, Kamiya T, Takagaki K, Ito H, Sugawa-Katayama Y, Tsuji H. Effects of young barley leaf powder on gastrointestinal functions in rats and its efficacy-related physicochemical properties. Evid Based Complement Alternat Med. 2014;2014:974840. doi: 10.1155/2014/974840. Epub 2014 Jul 08. PMID: 25114709; PMCID: PMC4119638.
Copy Download .nbib Format: NLM
Anti-Diabetic Potential of Ocimum gratissimum Leaf Fractions in Fortified Diet-Fed Streptozotocin Treated Rat Model of Type-2 Diabetes.

Medicines (Basel, Switzerland)

Okoduwa SIR, Umar IA, James DB, Inuwa HM.
PMID: 29019956
Medicines (Basel). 2017 Oct 11;4(4). doi: 10.3390/medicines4040073.

No abstract available.

Cite
Okoduwa SIR, Umar IA, James DB, et al. Anti-Diabetic Potential of Ocimum gratissimum Leaf Fractions in Fortified Diet-Fed Streptozotocin Treated Rat Model of Type-2 Diabetes. Medicines (Basel). 2017;4(4)doi: 10.3390/medicines4040073.
Okoduwa, S. I. R., Umar, I. A., James, D. B., & Inuwa, H. M. (2017). Anti-Diabetic Potential of Ocimum gratissimum Leaf Fractions in Fortified Diet-Fed Streptozotocin Treated Rat Model of Type-2 Diabetes. Medicines (Basel, Switzerland), 4(4), . https://doi.org/10.3390/medicines4040073
Okoduwa, Stanley I R, et al. "Anti-Diabetic Potential of Ocimum gratissimum Leaf Fractions in Fortified Diet-Fed Streptozotocin Treated Rat Model of Type-2 Diabetes." Medicines (Basel, Switzerland) vol. 4,4 (2017). doi: https://doi.org/10.3390/medicines4040073
Okoduwa SIR, Umar IA, James DB, Inuwa HM. Anti-Diabetic Potential of Ocimum gratissimum Leaf Fractions in Fortified Diet-Fed Streptozotocin Treated Rat Model of Type-2 Diabetes. Medicines (Basel). 2017 Oct 11;4(4). doi: 10.3390/medicines4040073. PMID: 29019956; PMCID: PMC5750597.
Copy Download .nbib Format: NLM
Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis.

Journal of clinical biochemistry and nutrition

Shimizu Y, Dobashi K, Nagase H, Ohta K, Sano T, Matsuzaki S, Ishii Y, Satoh T, Koka M, Yokoyama A, Ohkubo T, Ishii Y, Kamiya T.
PMID: 25834305
J Clin Biochem Nutr. 2015 Jan;56(1):74-83. doi: 10.3164/jcbn.14-44. Epub 2014 Nov 28.

The cellular mechanisms involved in the development of silicosis have not been fully elucidated. This study aimed to examine influence of silica-induced lung injury on autophagy. Suspensions of crystalline silica particles were administered transnasally to C57BL/6j mice. Immunohistochemical examination...

Cite
Shimizu Y, Dobashi K, Nagase H, et al. Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis. J Clin Biochem Nutr. 2014;56(1):74-83doi: 10.3164/jcbn.14-44.
Shimizu, Y., Dobashi, K., Nagase, H., Ohta, K., Sano, T., Matsuzaki, S., Ishii, Y., Satoh, T., Koka, M., Yokoyama, A., Ohkubo, T., Ishii, Y., & Kamiya, T. (2015). Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis. Journal of clinical biochemistry and nutrition, 56(1), 74-83. https://doi.org/10.3164/jcbn.14-44
Shimizu, Yasuo, et al. "Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis." Journal of clinical biochemistry and nutrition vol. 56,1 (2015): 74-83. doi: https://doi.org/10.3164/jcbn.14-44
Shimizu Y, Dobashi K, Nagase H, Ohta K, Sano T, Matsuzaki S, Ishii Y, Satoh T, Koka M, Yokoyama A, Ohkubo T, Ishii Y, Kamiya T. Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis. J Clin Biochem Nutr. 2015 Jan;56(1):74-83. doi: 10.3164/jcbn.14-44. Epub 2014 Nov 28. PMID: 25834305; PMCID: PMC4306660.
Copy Download .nbib Format: NLM
The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitis.

Journal of clinical medicine research

Tanida S, Mizoshita T, Ozeki K, Tsukamoto H, Mori Y, Kubota E, Kataoka H, Kamiya T, Joh T.
PMID: 25436030
J Clin Med Res. 2015 Feb;7(2):118-21. doi: 10.14740/jocmr1991w. Epub 2014 Nov 19.

A 43-year-old woman, diagnosed with ulcerative colitis (UC) at age of 30, received outpatient treatment with corticosteroids. However, flare-up occurred, and adalimumab (ADA) treatment commenced in July 2009. A complete remission with mucosal healing was achieved by 32 weeks...

Cite
Tanida S, Mizoshita T, Ozeki K, et al. The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitis. J Clin Med Res. 2014;7(2):118-21doi: 10.14740/jocmr1991w.
Tanida, S., Mizoshita, T., Ozeki, K., Tsukamoto, H., Mori, Y., Kubota, E., Kataoka, H., Kamiya, T., & Joh, T. (2015). The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitis. Journal of clinical medicine research, 7(2), 118-21. https://doi.org/10.14740/jocmr1991w
Tanida, Satoshi, et al. "The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitis." Journal of clinical medicine research vol. 7,2 (2015): 118-21. doi: https://doi.org/10.14740/jocmr1991w
Tanida S, Mizoshita T, Ozeki K, Tsukamoto H, Mori Y, Kubota E, Kataoka H, Kamiya T, Joh T. The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitis. J Clin Med Res. 2015 Feb;7(2):118-21. doi: 10.14740/jocmr1991w. Epub 2014 Nov 19. PMID: 25436030; PMCID: PMC4245064.
Copy Download .nbib Format: NLM
n-type conversion of SnS by isovalent ion substitution: Geometrical doping as a new doping route.

Scientific reports

Ran FY, Xiao Z, Toda Y, Hiramatsu H, Hosono H, Kamiya T.
PMID: 26020855
Sci Rep. 2015 May 28;5:10428. doi: 10.1038/srep10428.

Tin monosulfide (SnS) is a naturally p-type semiconductor with a layered crystal structure, but no reliable n-type SnS has been obtained by conventional aliovalent ion substitution. In this work, carrier polarity conversion to n-type was achieved by isovalent ion...

Cite
Ran FY, Xiao Z, Toda Y, et al. n-type conversion of SnS by isovalent ion substitution: Geometrical doping as a new doping route. Sci Rep. 2015;5:10428doi: 10.1038/srep10428.
Ran, F. Y., Xiao, Z., Toda, Y., Hiramatsu, H., Hosono, H., & Kamiya, T. (2015). n-type conversion of SnS by isovalent ion substitution: Geometrical doping as a new doping route. Scientific reports, 510428. https://doi.org/10.1038/srep10428
Ran, Fan-Yong, et al. "n-type conversion of SnS by isovalent ion substitution: Geometrical doping as a new doping route." Scientific reports vol. 5 (2015): 10428. doi: https://doi.org/10.1038/srep10428
Ran FY, Xiao Z, Toda Y, Hiramatsu H, Hosono H, Kamiya T. n-type conversion of SnS by isovalent ion substitution: Geometrical doping as a new doping route. Sci Rep. 2015 May 28;5:10428. doi: 10.1038/srep10428. PMID: 26020855; PMCID: PMC4446993.
Copy Download .nbib Format: NLM
Evaluation of Kampo medicine in the clinical practice guideline for irritable bowel syndrome.

Journal of gastroenterology

Fukudo S, Kaneko H, Akiho H, Inamori M, Endo Y, Okumura T, Kanazawa M, Kamiya T, Sato K, Chiba T, Furuta K, Yamato S, Arakawa T, Fujiyama Y, Azuma T, Fujimoto K, Mine T, Miura S, Kinoshita Y, Watanabe M, Sugano K, Shimosegawa T.
PMID: 26100007
J Gastroenterol. 2015 Jul;50(7):817-8. doi: 10.1007/s00535-015-1074-z. Epub 2015 Jun 23.

No abstract available.

Cite
Fukudo S, Kaneko H, Akiho H, et al. Evaluation of Kampo medicine in the clinical practice guideline for irritable bowel syndrome. J Gastroenterol. 2015;50(7):817-8doi: 10.1007/s00535-015-1074-z.
Fukudo, S., Kaneko, H., Akiho, H., Inamori, M., Endo, Y., Okumura, T., Kanazawa, M., Kamiya, T., Sato, K., Chiba, T., Furuta, K., Yamato, S., Arakawa, T., Fujiyama, Y., Azuma, T., Fujimoto, K., Mine, T., Miura, S., Kinoshita, Y., Watanabe, M., Sugano, K., & Shimosegawa, T. (2015). Evaluation of Kampo medicine in the clinical practice guideline for irritable bowel syndrome. Journal of gastroenterology, 50(7), 817-8. https://doi.org/10.1007/s00535-015-1074-z
Fukudo, Shin, et al. "Evaluation of Kampo medicine in the clinical practice guideline for irritable bowel syndrome." Journal of gastroenterology vol. 50,7 (2015): 817-8. doi: https://doi.org/10.1007/s00535-015-1074-z
Fukudo S, Kaneko H, Akiho H, Inamori M, Endo Y, Okumura T, Kanazawa M, Kamiya T, Sato K, Chiba T, Furuta K, Yamato S, Arakawa T, Fujiyama Y, Azuma T, Fujimoto K, Mine T, Miura S, Kinoshita Y, Watanabe M, Sugano K, Shimosegawa T. Evaluation of Kampo medicine in the clinical practice guideline for irritable bowel syndrome. J Gastroenterol. 2015 Jul;50(7):817-8. doi: 10.1007/s00535-015-1074-z. Epub 2015 Jun 23. PMID: 26100007.
Copy Download .nbib Format: NLM
Anti-inflammatory effect of amlodipine plus atorvastatin treatment on carotid atherosclerosis in zucker metabolic syndrome rats.

Translational stroke research

Zhang X, Tian F, Kawai H, Kurata T, Deguchi S, Deguchi K, Shang J, Liu N, Liu W, Ikeda Y, Matsuura T, Kamiya T, Abe K.
PMID: 24323832
Transl Stroke Res. 2012 Dec;3(4):435-41. doi: 10.1007/s12975-012-0198-1. Epub 2012 Jul 21.

To investigate the effects of amlodipine in combination with atorvastatin on carotid atherosclerotic changes in metabolic syndrome, 8-week-old Zucker fatty rats were treated with vehicle, amlodipine, atorvastatin, or amlodipine in combination with atorvastatin for 28 days. Histological studies of...

Cite
Zhang X, Tian F, Kawai H, et al. Anti-inflammatory effect of amlodipine plus atorvastatin treatment on carotid atherosclerosis in zucker metabolic syndrome rats. Transl Stroke Res. 2012;3(4):435-41doi: 10.1007/s12975-012-0198-1.
Zhang, X., Tian, F., Kawai, H., Kurata, T., Deguchi, S., Deguchi, K., Shang, J., Liu, N., Liu, W., Ikeda, Y., Matsuura, T., Kamiya, T., & Abe, K. (2012). Anti-inflammatory effect of amlodipine plus atorvastatin treatment on carotid atherosclerosis in zucker metabolic syndrome rats. Translational stroke research, 3(4), 435-41. https://doi.org/10.1007/s12975-012-0198-1
Zhang, Xuemei, et al. "Anti-inflammatory effect of amlodipine plus atorvastatin treatment on carotid atherosclerosis in zucker metabolic syndrome rats." Translational stroke research vol. 3,4 (2012): 435-41. doi: https://doi.org/10.1007/s12975-012-0198-1
Zhang X, Tian F, Kawai H, Kurata T, Deguchi S, Deguchi K, Shang J, Liu N, Liu W, Ikeda Y, Matsuura T, Kamiya T, Abe K. Anti-inflammatory effect of amlodipine plus atorvastatin treatment on carotid atherosclerosis in zucker metabolic syndrome rats. Transl Stroke Res. 2012 Dec;3(4):435-41. doi: 10.1007/s12975-012-0198-1. Epub 2012 Jul 21. PMID: 24323832.
Copy Download .nbib Format: NLM
Organizing Pneumonia in a Patient with Quiescent Crohn's Disease.

Case reports in gastrointestinal medicine

Tanida S, Takemura M, Mizoshita T, Ozeki K, Katano T, Shimura T, Mori Y, Kubota E, Kataoka H, Kamiya T, Joh T.
PMID: 27413560
Case Rep Gastrointest Med. 2016;2016:8129864. doi: 10.1155/2016/8129864. Epub 2016 Jun 20.

A 64-year-old man with Crohn's disease (CD) was admitted to our hospital due to moderate risk of pneumonia while receiving scheduled adalimumab maintenance therapy. Symptoms remained virtually unchanged following administration of antibiotics. A final diagnosis of organizing pneumonia (OP)...

Cite
Tanida S, Takemura M, Mizoshita T, et al. Organizing Pneumonia in a Patient with Quiescent Crohn's Disease. Case Rep Gastrointest Med. 2016;2016:8129864doi: 10.1155/2016/8129864.
Tanida, S., Takemura, M., Mizoshita, T., Ozeki, K., Katano, T., Shimura, T., Mori, Y., Kubota, E., Kataoka, H., Kamiya, T., & Joh, T. (2016). Organizing Pneumonia in a Patient with Quiescent Crohn's Disease. Case reports in gastrointestinal medicine, 20168129864. https://doi.org/10.1155/2016/8129864
Tanida, Satoshi, et al. "Organizing Pneumonia in a Patient with Quiescent Crohn's Disease." Case reports in gastrointestinal medicine vol. 2016 (2016): 8129864. doi: https://doi.org/10.1155/2016/8129864
Tanida S, Takemura M, Mizoshita T, Ozeki K, Katano T, Shimura T, Mori Y, Kubota E, Kataoka H, Kamiya T, Joh T. Organizing Pneumonia in a Patient with Quiescent Crohn's Disease. Case Rep Gastrointest Med. 2016;2016:8129864. doi: 10.1155/2016/8129864. Epub 2016 Jun 20. PMID: 27413560; PMCID: PMC4931091.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 590 entries